NERM
CELG

New England Research & Management’s Celgene Corp CELG Stock Holding History

New England Research & Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16,616
Closed -$1.06M – 186
2018
Q4 		$1.06M Sell
16,616
-610
-4% -$45K 0.84% 42
2018
Q3 		$1.54M Sell
17,226
-1,450
-8% -$128K 1% 31
2018
Q2 		$1.48M Buy
18,676
+900
+5% +$74.7K 0.98% 30
2018
Q1 		$1.59M Buy
17,776
+5,150
+41% +$494K 1.06% 24
2017
Q4 		$1.32M Buy
12,626
+1,792
+17% +$202K 0.94% 38
2017
Q3 		$1.58M Sell
10,834
-350
-3% -$47.7K 1.16% 22
2017
Q2 		$1.45M Buy
11,184
+1,234
+12% +$151K 1.07% 25
2017
Q1 		$1.24M Sell
9,950
-1,325
-12% -$159K 0.95% 29
2016
Q4 		$1.3M Sell
11,275
-3,480
-24% -$388K 1.02% 22
2016
Q3 		$1.54M Sell
14,755
-3,000
-17% -$325K 1.29% 14
2016
Q2 		$1.75M Sell
17,755
-275
-2% -$28.4K 1.51% 9
2016
Q1 		$1.8M Buy
18,030
+2,300
+15% +$237K 1.53% 10
2015
Q4 		$1.88M Sell
15,730
-470
-3% -$54.4K 1.63% 9
2015
Q3 		$1.75M Buy
16,200
+135
+0.8% +$16.8K 1.67% 10
2015
Q2 		$1.86M Buy
16,065
+3,615
+29% +$413K 1.52% 8
2015
Q1 		$1.44M Buy
12,450
+1,325
+12% +$158K 1.23% 14
2014
Q4 		$1.24M Sell
11,125
-2,305
-17% -$243K 1.07% 15
2014
Q3 		$1.27M Sell
13,430
-50
-0.4% -$4.51K 1.11% 15
2014
Q2 		$1.16M Sell
13,480
-2,150
-14% -$164K 1.04% 24
2014
Q1 		$1.09M Sell
15,630
-1,170
-7% -$92.7K 1% 29
2013
Q4 		$1.42M Buy
+16,800
New +$1.33M 1.37% 13

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New England Research & Management's CELG Position: Q1 2019 in Review

New England Research & Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 16,616 shares — an estimated $1.06M sold.

New England Research & Management first reported a position in CELG in Q4 2013 and held it in 21 quarters. The position peaked at $1.88M in Q4 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • New England Research & Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • New England Research & Management sold 16,616 Celgene Corp shares in Q1 2019, an estimated $1.06M.
  • New England Research & Management first reported a position in Celgene Corp in Q4 2013 and held it in 21 quarters.
  • New England Research & Management's Celgene Corp position peaked at $1.88M in Q4 2015.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on New England Research & Management's 13F filing for Q1 2019, filed 3 Apr 2019.